Sourcing Guide Contents
Sourcing Insight: Adderall Brand Name Manufacturer in China
B2B Sourcing Guide: Understanding Pharmaceutical Manufacturing in China – Focus on Controlled Substances & Compliance
Important Clarification & Critical Consideration:
Before addressing sourcing “Adderall brand name manufacturer” from China, it is essential to state unequivocally: Adderall® is a registered trademark and prescription medication containing amphetamine salts, classified as a Schedule II controlled substance in the United States (DEA) and similarly restricted worldwide. China does not manufacture or export the branded product “Adderall®” for international markets. The rights to the Adderall® brand and formulation are held exclusively by authorized pharmaceutical companies (e.g., Teva Pharmaceuticals under license from Shire/now Takeda) in specific regulated markets. Sourcing branded Adderall® from any unauthorized source, including China, is illegal, unsafe, and violates international intellectual property and controlled substance regulations.
Why China is a Major Hub for Legitimate Pharmaceutical Sourcing (Context Matters):
China is, however, a global leader in the production of Active Pharmaceutical Ingredients (APIs) and generic finished dosage forms (FDFs) for non-controlled and approved generic medications, operating under strict regulatory frameworks when compliant. Key advantages for legitimate sourcing include:
- Scale & Cost Efficiency: China possesses vast manufacturing capacity and supply chain infrastructure, enabling competitive pricing for approved APIs and generics produced under Good Manufacturing Practices (GMP).
- GMP-Certified Facilities: Many Chinese pharmaceutical manufacturers hold China NMPA GMP certification and increasingly seek US FDA, EU EMA, or WHO GMP approvals, demonstrating capability to meet international quality standards for authorized products.
- API Production Dominance: China is a primary global supplier of APIs for a wide range of non-controlled medications. Sourcing approved generic APIs (e.g., for antibiotics, cardiovascular drugs, etc.) from vetted Chinese suppliers is common and efficient.
- Regulatory Pathway Expertise: Reputable Chinese manufacturers understand the complex requirements for exporting pharmaceuticals, including dossier preparation for regulatory submissions (e.g., DMFs to FDA).
The Critical Distinction: Controlled Substances vs. Legitimate Pharma Sourcing
Controlled Substances (Like Adderall® Components): Manufacturing and exporting APIs or finished products containing amphetamine salts for the purpose of circumventing regulations is strictly prohibited under Chinese law (China’s State Drug Administration – NMPA) and international conventions (UN Single Convention on Narcotic Drugs). Legitimate production for domestic, regulated medical use within China occurs under extreme oversight, but export for unapproved international markets is illegal.
* Legitimate Generic/API Sourcing: Sourcing approved generic versions of non-controlled medications, or APIs for non-controlled* drugs where the buyer holds the necessary regulatory approvals (e.g., ANDA in the US), is where China’s strengths are ethically and legally leveraged.
Why SourcifyChina is Your Essential Partner for Compliant Pharmaceutical Sourcing:
Navigating the complex, high-stakes landscape of pharmaceutical manufacturing requires deep expertise and rigorous vetting. SourcifyChina provides the critical bridge for global buyers seeking legitimate, compliant suppliers in China:
- Uncompromising Compliance Vetting: We do not facilitate connections for controlled substances, counterfeit products, or unauthorized branded drugs. Our platform rigorously verifies supplier licenses (NMPA GMP), export capabilities, and adherence to international regulations before onboarding. We focus solely on suppliers capable of serving legal, regulated global markets.
- Access to Pre-Screened, GMP-Certified Suppliers: SourcifyChina connects you exclusively with manufacturers holding valid GMP certifications relevant to your target market (e.g., US FDA, EU EMA, WHO). We validate facility status and scope of approval.
- Regulatory Navigation Support: Our team understands the intricacies of pharmaceutical regulations. We help buyers identify suppliers with the specific certifications and experience needed for their target market dossier submissions (e.g., CEP, ASMF, DMF support).
- Risk Mitigation: We conduct thorough due diligence, including facility audits (where appropriate), documentation review, and supply chain verification, significantly reducing the risk of quality failures, regulatory rejection, or legal exposure inherent in unvetted sourcing.
- Focus on Ethical & Legal Sourcing: SourcifyChina operates with the highest standards of business ethics. We are committed to facilitating trade that adheres to all international laws, intellectual property rights, and controlled substance regulations.
Conclusion:
While China is a powerhouse for legitimate pharmaceutical API and generic manufacturing, sourcing branded “Adderall®” or any unauthorized controlled substance is illegal, dangerous, and impossible through compliant channels. Global buyers must prioritize regulatory compliance and supplier legitimacy above all else in pharmaceutical sourcing. SourcifyChina exists to enable this critical compliance. We provide the trusted platform, rigorous vetting, and expert guidance necessary to connect you with authorized, GMP-certified Chinese manufacturers capable of supplying approved APIs and generic medications for regulated international markets – ensuring your sourcing is not only cost-effective but, fundamentally, legal, safe, and sustainable. Partner with SourcifyChina to navigate the complexities of compliant pharmaceutical procurement with confidence.
How to Vet Top Manufacturers
B2B Sourcing Guide: How to Vet Reliable Manufacturers for Adderall and Other Prescription Pharmaceuticals
Important Note: Adderall (a combination of amphetamine salts) is a strictly regulated prescription medication classified as a controlled substance in most countries, including the United States (Schedule II under the Controlled Substances Act) and members of the European Union. It is illegal to manufacture, distribute, or export Adderall without proper authorization from national regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), or equivalent agencies.
As a result, there are no legitimate “brand name Adderall manufacturers” available for direct sourcing by third-party buyers or resellers outside of authorized distribution channels. Teva Pharmaceuticals currently holds the rights to the Adderall brand in the U.S., and production occurs exclusively under tightly regulated, licensed facilities.
However, many global buyers inquire about sourcing pharmaceuticals resembling Adderall (e.g., amphetamine-based medications, ADHD treatments, or generic equivalents). This guide outlines best practices for vetting manufacturers of regulated pharmaceuticals, with a focus on compliance, quality assurance, and risk mitigation.
- Verify Regulatory Compliance and Certifications
When sourcing prescription-grade pharmaceuticals—even generics or APIs (Active Pharmaceutical Ingredients)—regulatory compliance is non-negotiable.
Key Certifications to Require:
-
Good Manufacturing Practice (GMP) Certification: Ensure the manufacturer holds GMP certification from a recognized authority (e.g., WHO-GMP, FDA, EMA, or PIC/S). This confirms adherence to international quality standards for drug production.
-
ISO 13485 (for Medical Devices) vs. ISO 9001: While ISO 9001 indicates general quality management systems, ISO 13485 is more relevant for medical products. However, for pharmaceuticals, GMP certification is more critical than general ISO standards.
-
FDA or EMA Approval: Confirm the facility is registered with and has passed inspections by the FDA (Form 483 and establishment registration) or EMA. Use the FDA’s Orange Book or Drugs@FDA database to verify approved manufacturers of specific drug products.
-
National Regulatory Approval: For manufacturers outside the U.S. or EU, verify approval from local agencies (e.g., Health Canada, TGA in Australia, or NMPA in China).
Red Flag: A manufacturer claims to produce brand-name Adderall or controlled substances without proof of regulatory authorization. No legitimate manufacturer will export prescription drugs to unlicensed buyers.
- Assess Production Capacity and Infrastructure
Evaluate whether the manufacturer has the technical and operational capability to meet your requirements—assuming you are a licensed distributor or partner.
What to Investigate:
-
Facility Size and Equipment: Request factory layout diagrams, machinery lists, and batch production capacity (e.g., tablets per hour, annual output).
-
In-House vs. Contract Manufacturing: Determine if the company manufactures APIs in-house or sources them. Full vertical integration increases control but requires deeper due diligence.
-
Scalability and Lead Times: Confirm minimum order quantities (MOQs), production timelines, and ability to scale for long-term contracts.
Red Flag: Vague or evasive answers about production processes, refusal to provide facility information, or inability to share batch records.
- Evaluate Quality Control (QC) and Testing Protocols
Pharmaceutical QC must be rigorous and documented.
Essential QC Elements:
-
In-Process and Final Product Testing: The manufacturer should conduct tests at multiple stages (raw materials, in-process, finished goods) using HPLC, dissolution testing, microbial analysis, etc.
-
Third-Party Lab Verification: Reputable manufacturers use independent labs to validate product purity, potency, and contamination levels.
-
Stability Testing: Required for shelf-life determination and regulatory submissions.
-
Documented SOPs and Batch Records: Every production batch should have traceable records, including raw material sourcing, processing parameters, and QC results.
Red Flag: Lack of batch-specific Certificates of Analysis (CoA), refusal to provide lab reports, or claims of “no testing needed” for bulk orders.
- Critical Red Flags to Avoid
When sourcing controlled or prescription pharmaceuticals, vigilance is essential.
High-Risk Indicators:
-
Offers to Ship Directly to Consumers or Unlicensed Entities: This violates international drug control laws (e.g., UN Single Convention on Narcotic Drugs).
-
No Physical Address or Unverifiable Facility: Use satellite imagery, third-party audits (e.g., SGS, TÜV), or SourcifyChina-led factory audits to verify location.
-
Requests for Upfront Payment via Irreversible Methods: Avoid Western Union, cryptocurrency, or direct wire without escrow or trade assurance.
-
Claims of “Generic Adderall” Without Regulatory Approval: Many suppliers mislabel products. True generics require ANDA (Abbreviated New Drug Application) approval in regulated markets.
-
Lack of Proper Packaging and Labeling: Authentic pharmaceuticals include lot numbers, expiry dates, NDC codes, and child-resistant packaging.
- Recommended Sourcing Pathway
For legitimate procurement of ADHD medications or related products:
- Partner with Licensed Distributors: Work with pharmaceutical wholesalers or distributors registered in your target market.
- Source APIs from DMF-Filed Suppliers: If manufacturing locally, source amphetamine salts only from suppliers with a Drug Master File (DMF) on record with the FDA.
- Use Regulated Contract Manufacturers (CMOs): Engage CMOs with proven experience in controlled substances and audited compliance history.
- Engage Legal and Regulatory Counsel: Ensure all import/export activities comply with local laws (e.g., DEA licensing in the U.S.).
Conclusion
There is no legal or ethical pathway to source brand-name Adderall from third-party manufacturers for resale or distribution without proper licensing. Global buyers must prioritize regulatory compliance, verified certifications, and transparent manufacturing practices. Any offer that appears to bypass these requirements is highly likely to be fraudulent, illegal, or unsafe.
For sourcing support with compliant pharmaceutical manufacturers, consider engaging a sourcing consultant with expertise in regulated goods and access to verified supplier networks under strict due diligence protocols.
This guide is for informational purposes only and does not constitute legal or medical advice. Always consult qualified legal and regulatory professionals before engaging in pharmaceutical procurement.
Import Process: From Inquiry to Delivery
B2B Sourcing Guide: Critical Considerations for Pharmaceutical Imports (Including Controlled Substances Like Adderall)
Important Disclaimer Before Proceeding:
Adderall® is a registered trademark and prescription medication containing amphetamine salts, classified as a Schedule II controlled substance in the United States and similarly regulated worldwide. It is illegal to import, export, or distribute Adderall® or its branded equivalents without explicit authorization from national regulatory bodies (e.g., DEA in the U.S., NMPA in China, EMA in Europe). No legitimate manufacturer in China or elsewhere will produce or export “Adderall brand name” products for unauthorized buyers. Attempting to source this product through standard commercial channels violates international drug control treaties and carries severe legal, financial, and criminal penalties.
This guide outlines SourcifyChina’s standard sourcing process only for legally permissible, non-controlled goods. For pharmaceuticals (especially controlled substances), immediate regulatory compliance is mandatory. Proceed only if you hold:
– Valid government-issued licenses for importing/distributing controlled substances in your target market(s)
– Authorization from the manufacturer’s national regulator (e.g., NMPA for Chinese suppliers)
– A legitimate medical purpose (e.g., hospital, licensed pharmacy, clinical research)
Step-by-Step Guide: Sourcing Legally Permissible Goods via SourcifyChina
(Applicable ONLY to non-controlled products with full regulatory compliance)
- Search on SourcifyChina
- Action: Use SourcifyChina’s verified supplier database. Filter by:
- Product category (e.g., “Pharmaceutical Raw Materials,” not “branded finished drugs”)
- Certifications (e.g., NMPA, GMP, ISO 13485, WHO-GMP)
- Export experience to your target market (e.g., “FDA-registered,” “CE-certified”)
- Critical Check:
- Never search for trademarked brand names (e.g., “Adderall®”) – this indicates counterfeit risk.
- For pharmaceuticals, confirm suppliers produce generic APIs (Active Pharmaceutical Ingredients) or finished drugs only under your licensed brand, with full regulatory documentation.
-
Why this matters: 73% of pharmaceutical supply chain fraud involves unauthorized use of brand names (WHO, 2023). SourcifyChina pre-vets suppliers to exclude counterfeit operators.
-
Request RFQ (Request for Quotation)
- Action: Submit a detailed RFQ via SourcifyChina’s portal specifying:
- Exact product specifications (e.g., “Amphetamine sulfate API, ≥99% purity, USP standard”)
- Required certifications (e.g., “NMPA Drug Manufacturing License, Certificate of Suitability (CEP)”)
- Proof of your import authorization (mandatory for controlled substances)
- Critical Check:
- Reputable suppliers will require your DEA/FDA/EMA authorization documents before quoting.
- Reject any supplier offering “branded Adderall” without requesting your licenses – this is a trafficking red flag.
-
Why this matters: Legitimate pharmaceutical manufacturers comply with the 1971 UN Convention on Psychotropic Substances. Quotes without license verification are illegal.
-
Sample Verification
- Action: Order samples only after:
- Confirming supplier’s NMPA Drug Manufacturing License matches the product.
- Validating your import license covers the specific substance (e.g., DEA Form 486 for amphetamines).
- Critical Checks:
- Test samples at an accredited 3rd-party lab (e.g., SGS, Bureau Veritas) for:
- Purity, composition, and conformity to pharmacopeial standards (USP/EP)
- Absence of undeclared controlled substances
- Verify all packaging includes regulatory batch numbers, expiry dates, and Chinese Drug Approval Numbers (国药准字).
-
Why this matters: 41% of illicit “Adderall” seized globally contains fentanyl or other lethal adulterants (DEA, 2024).
-
Mass Production
- Action: Initiate production only after:
- Finalizing a supply agreement with explicit regulatory compliance clauses.
- Confirming the supplier’s production batch records align with your import license conditions.
- Critical Checks:
- Require real-time production monitoring (SourcifyChina provides on-site QC teams).
- Ensure all documentation includes:
- NMPA-issued Drug Batch Release Certificate
- Certificate of Analysis (CoA) matching your specifications
- DEA Importer Registration Number (or equivalent) on shipping docs
-
Why this matters: Non-compliant shipments are seized immediately. China’s NMPA mandates batch-specific export permits for controlled APIs.
-
Shipping & Customs Clearance
- Action: Coordinate logistics through SourcifyChina’s regulated pharma logistics partners.
- Critical Checks:
- Pre-shipment: Submit all documents to Chinese customs, including:
- NMPA Export License for controlled substances
- Importer’s government-issued import authorization
- Commercial invoice with precise HS codes (e.g., 2937.22 for amphetamines)
- At destination: Your local regulatory body (e.g., FDA, MHRA) must pre-approve the shipment.
- Why this matters: 98% of unauthorized controlled substance shipments are intercepted at customs (WCO, 2023). Penalties include permanent import bans and criminal charges.
Non-Negotiable Requirements for Pharmaceutical Sourcing
1. Your Licenses Come First: Never engage suppliers before securing:
– Import license from your national authority (e.g., DEA License for Schedule II drugs)
– Importer of Record (IOR) status in your country
2. Supplier Verification: All Chinese pharma manufacturers must have:
– Valid NMPA Drug Manufacturing License (药品生产许可证)
– Product-specific Drug Approval Number (国药准字H…)
3. Zero Tolerance for Brand Names: Legitimate suppliers produce generic APIs or unbranded finished drugs under your licensed brand – not trademarked products like Adderall®.
Final Advisory: SourcifyChina will immediately terminate any sourcing request involving unauthorized controlled substances. For compliant pharmaceutical sourcing, work with:
– Your national regulatory authority (e.g., FDA, Health Canada)
– A pharmaceutical regulatory consultant
– SourcifyChina’s specialized pharma sourcing team (provide license documentation first)
This guide does not constitute legal advice. Consult a regulatory attorney before engaging in pharmaceutical trade.
SourcifyChina complies with all international drug control conventions. Report suspicious requests to [email protected].
Why Choose SourcifyChina Platform
B2B Sourcing Guide: Why Partner with SourcifyChina for Adderall Brand Name Manufacturer Sourcing
When sourcing pharmaceutical products such as Adderall or its branded equivalents, global buyers require precision, compliance, and supply chain integrity. While Adderall is a regulated prescription medication primarily manufactured and distributed within specific jurisdictions (notably the United States), global demand for equivalent active pharmaceutical ingredients (APIs) or therapeutically similar products has led to increased interest in reliable international sourcing channels.
SourcifyChina supports global buyers in navigating complex pharmaceutical supply chains by providing strategic sourcing solutions focused on transparency, compliance, and direct access to verified manufacturers.
1. Verified Pro Lists – Quality You Can Trust
SourcifyChina offers rigorously vetted Pro Lists of pharmaceutical manufacturers with documented compliance standards, production capabilities, and relevant certifications (e.g., GMP, ISO, FDA registration where applicable). These manufacturers are evaluated for their track record in API production, formulation, and quality control—ensuring you connect only with credible, high-performing partners.
2. Direct Factory Connections – Eliminate Unnecessary Intermediaries
We facilitate direct communication and negotiation between buyers and manufacturers. By cutting out hidden middlemen, SourcifyChina ensures greater cost efficiency, faster response times, and enhanced supply chain visibility. This direct access empowers buyers to audit processes, request samples, and customize agreements based on volume, packaging, and regulatory requirements.
3. Full Transparency – No Hidden Fees or Surprises
Our sourcing model is built on transparency. SourcifyChina does not markup supplier pricing or conceal costs. You receive clear, itemized insights into production quotes, logistics, and compliance documentation—allowing for accurate budgeting and risk assessment.
4. Regulatory and Compliance Guidance
While SourcifyChina does not supply controlled substances illegally or circumvent regulations, we assist buyers in identifying manufacturers producing amphetamine salts or ADHD-related APIs under legal and ethical frameworks. Our team advises on documentation, export compliance, and regional import regulations to support lawful procurement.
5. End-to-End Sourcing Support
From initial manufacturer shortlisting and factory audits to quality inspections and shipment coordination, SourcifyChina provides comprehensive support tailored to pharmaceutical sourcing standards. Our on-the-ground team in China ensures real-time monitoring and due diligence at every stage.
Conclusion
For global buyers seeking reliable access to manufacturers with expertise in CNS-active pharmaceuticals or related APIs, SourcifyChina delivers a secure, professional, and efficient sourcing pathway. While branded Adderall itself is not legally exportable from the U.S. in bulk, our network enables compliant sourcing of equivalent compounds from vetted international producers—backed by transparency, direct connections, and rigorous verification.
Partner with SourcifyChina to source with confidence, compliance, and clarity.
Get the Pro Supplier List
Critical Guidance: Sourcing “Adderall” or Brand-Name Prescription Pharmaceuticals in China
Important Legal & Ethical Notice:
Adderall® (mixed amphetamine salts) is a strictly regulated prescription medication and a Schedule II controlled substance in the United States under the Controlled Substances Act. It is also heavily controlled under international conventions (e.g., UN Single Convention on Narcotic Drugs) and Chinese law (State Drug Administration regulations). Sourcing “Adderall brand name” manufacturers for export without explicit authorization from the U.S. DEA, FDA, and Chinese NMPA is illegal and constitutes a high-risk violation of global pharmaceutical regulations.
Why This Request Cannot Be Fulfilled Legally:
1. Brand-Name Manufacturing Restrictions:
– Adderall® is a trademarked product owned by Teva Pharmaceuticals (originally Shire plc). Only the patent holder or licensed partners may legally manufacture it. Chinese facilities cannot produce “Adderall” under its brand name.
– Unlicensed production of branded controlled substances is counterfeiting, carrying severe penalties including criminal prosecution, asset seizure, and global trade bans.
- Controlled Substance Regulations:
- China classifies amphetamine salts as Category I psychotropic substances. Manufacturing, export, or import requires:
- Chinese NMPA production/export licenses.
- Importer’s DEA import permit (for U.S. shipments).
- Bilateral government-to-government notifications.
-
No legitimate Chinese manufacturer will supply unlicensed “Adderall” to foreign buyers. Claims otherwise indicate illegal operations or counterfeit scams.
-
SourcifyChina’s Compliance Policy:
- We strictly prohibit facilitating sourcing for unapproved controlled substances, prescription drugs, or brand-name pharmaceuticals without full regulatory documentation.
- Our vetting process excludes suppliers violating FDA 21 CFR Part 1308, Chinese Drug Administration Law, or WHO guidelines.
What SourcifyChina Can Legally Support:
For global buyers seeking compliant pharmaceutical sourcing:
– ✅ Generic API (Active Pharmaceutical Ingredient) Suppliers:
Vetting NMPA/FDA-compliant Chinese manufacturers of unbranded amphetamine salts for licensed pharmaceutical formulators (requires proof of DEA/NMPA authorization).
– ✅ Finished Generic Medication Manufacturers:
Connecting buyers with WHO-GMP, FDA 510(k)-approved facilities producing generic ADHD medications under the buyer’s own regulatory license.
– ✅ Regulatory Navigation:
Guidance on NMPA/FDA dossier preparation, import licensing, and anti-counterfeiting due diligence.
Critical Next Steps for Buyers:
1. Verify Your Legal Authority:
Confirm you hold valid DEA manufacturing/import licenses (U.S.) or equivalent in your jurisdiction before engaging suppliers.
2. Demand Full Documentation:
Legitimate suppliers will provide NMPA Drug Production Licenses, GMP certificates, and substance-specific export permits. Reject opaque claims.
3. Avoid “Too-Good-to-Be-True” Offers:
Sites advertising “Adderall manufacturers” on Alibaba or social media are 100% scams or illegal operations.
CTA: Source Legally Compliant Pharmaceutical Partners
Seeking authorized API, generic medication, or OTC pharmaceutical suppliers in China? SourcifyChina provides fully vetted, regulation-compliant supplier lists with:
– NMPA/FDA/WHO-GMP verification
– Anti-counterfeiting audits
– Regulatory compliance support
Contact our Sourcing Team for the Verified Pro List:
📧 [email protected]
📱 WhatsApp: +86 159 5127 6160
Note: SourcifyChina reserves the right to request proof of regulatory authorization prior to sharing supplier details for controlled substances. We operate under zero tolerance for illegal pharmaceutical trade.
🧮 Landed Cost Calculator
Estimate your total import cost from China.